These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2787379)

  • 21. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T cell clones against human autologous cancers: analysis of target antigen and the mechanism of specific target cell destruction.
    Kikuchi K; Okubo M; Sato T; Sato N
    Princess Takamatsu Symp; 1988; 19():303-13. PubMed ID: 3269362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic aspects of tumor induction by ultraviolet radiation.
    Kripke ML; Fisher MS
    Natl Cancer Inst Monogr; 1978 Dec; (50):179-83. PubMed ID: 753974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
    Dudley ME; Roopenian DC
    J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
    Flood PM; Schreiber H; Ron Y
    J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones.
    Wortzel RD; Urban JL; Philipps C; Fitch FW; Schreiber H
    J Immunol; 1983 May; 130(5):2461-6. PubMed ID: 6187859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactive transplantation antigens between UV-irradiated skin and UV-induced tumors.
    Spellman CW; Daynes RA
    Photodermatol; 1984 Aug; 1(4):164-9. PubMed ID: 6397735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. Growth and induction of nonultraviolet-induced tumors in ultraviolet-irradiated mice.
    Kripke ML; Thorn RM; Lill PH; Civin CI; Pazmiño NH; Fisher MS
    Transplantation; 1979 Sep; 28(3):212-7. PubMed ID: 91250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of parent genetic background on latency and antigenicity of UV-induced tumors originating in F1 hybrids.
    Kitajima T; Iwashiro M; Kuribayashi K; Imamura S
    Exp Dermatol; 1995 Feb; 4(1):42-5. PubMed ID: 7757331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of helper T-lymphocytes in rejection of UV-induced murine skin cancers.
    Romerdahl CA; Kripke ML
    Cancer Res; 1988 May; 48(9):2325-8. PubMed ID: 2965612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultraviolet carcinogenesis in athymic nude mice.
    Hoover TL; Morison WL; Kripke ML
    Transplantation; 1987 Nov; 44(5):693-5. PubMed ID: 3500533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes.
    Koeppen H; Acena M; Drolet A; Rowley DA; Schreiber H
    Eur J Immunol; 1993 Nov; 23(11):2770-6. PubMed ID: 8223853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic responses of the autochthonous host against tumors induced by ultraviolet light.
    Kripke ML; Fisher MS
    Adv Exp Med Biol; 1976; 66():445-9. PubMed ID: 1266675
    [No Abstract]   [Full Text] [Related]  

  • 34. Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. II. Studies on the origin and activity of ultraviolet-induced suppressor lymphocytes.
    Thorn RM; Fisher MS; Kripke ML
    Transplantation; 1981 Feb; 31(2):129-33. PubMed ID: 6973223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
    Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
    J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses.
    Matsubayashi Y; Hirama T; Morioka A; Iwashiro M; Masuda T; Uchino H; Takeshita S; Yamagishi H; Udono H; Mieno M
    Eur J Immunol; 1990 Sep; 20(9):2095-103. PubMed ID: 1698639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.
    Perdrizet GA; Ross SR; Stauss HJ; Singh S; Koeppen H; Schreiber H
    J Exp Med; 1990 Apr; 171(4):1205-20. PubMed ID: 2324687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo immune responses of mice during carcinogenesis by ultraviolet irradiation.
    Kripke ML; Lofgreen JS; Beard J; Jessup JM; Fisher MS
    J Natl Cancer Inst; 1977 Oct; 59(4):1227-30. PubMed ID: 20514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.